Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites

American Journal of Infection Control

Volumn 43, Issue 7, 2015, Pages 711-714

  Lorente, Leonardo ^a   Lecuona, María ^a   Jiménez, Alejandro ^a   Lorenzo, Lisset ^a   Santacreu, Ruth ^a   Ramos, Silvia ^a   Hurtado, Eva ^a   Buitrago, Manuel ^a   Mora, María L ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Bacteremia; Central venous catheter

Indexed keywords

CHLORHEXIDINE; SULFADIAZINE SILVER; DISINFECTANT AGENT;

ADULT; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COST EFFECTIVENESS ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SUBCLAVIAN VEIN CATHETER; VASCULAR ACCESS; AGED; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; COST; DISINFECTION; ECONOMICS; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; SPAIN; SUBCLAVIAN VEIN;

ADULT; AGED; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; COSTS AND COST ANALYSIS; DISINFECTANTS; DISINFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SILVER SULFADIAZINE; SPAIN; SUBCLAVIAN VEIN;

EID: 84946166828     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.03.019     Document Type: Article

References (20)

1. J.L. Vincent, D.J. Bihari, P.M. Suter, H.A. Bruining, J. White, M.H. Nicolas-Chanoin the EPIC International Advisory Committee The prevalence of nosocomial infection in Intensive Care Units in Europe JAMA 274 1995 639 644
2. I.I. Siempos, P. Kopterides, I. Tsangaris, I. Dimopoulou, and A.E. Armaganidis Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis Crit Care Med 37 2009 2283 2289
3. M.L. Lambert, C. Suetens, A. Savey, M. Palomar, M. Hiesmayr, I. Morales, and et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study Lancet Infect Dis 11 2011 30 38
4. K.B. Laupland, H. Lee, D.B. Gregson, and B.J. Manns Cost of intensive care unit-acquired bloodstream infections J Hosp Infect 63 2006 124 132
5. D.L. Veenstra, S. Saint, S. Saha, T. Lumley, and S.D. Sullivan Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis JAMA 281 1999 261 267
6. J.C. Hockenhull, K. Dwan, A. Boland, G. Smith, A. Bagust, and Y. Dündar The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation Health Technol Assess 12 2008 1 154
7. D.L. Veenstra, S. Saint, and S.D. Sullivan Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection JAMA 282 1999 554 560
8. A.F. Shorr, C.W. Humphreys, and D.L. Helman New choices for central venous catheters: potential financial implications Chest 124 2003 275 284
9. D. Pittet, D. Tarara, and R.P. Wenzel Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
10. J.B. Dimick, R.K. Pelz, R. Consunji, S.M. Swoboda, C.W. Hendrix, and P.A. Lipsett Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit Arch Surg 136 2001 229 234
11. L. Lorente, M. Lecuona, A. Jiménez, R. Santacreu, L. Raja, O. González, and et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs Am J Infect Control 42 2014 321 324
12. L. Lorente, M. Lecuona, A. Jiménez, L. Lorenzo, S. Diosdado, L. Marca, and et al. Cost/Benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access Am J Infect Control 42 2014 1130 1132
13. L. Lorente, C. Henry, M.M. Martín, A. Jiménez, and M.L. Mora Central venous catheter-related infection in a prospective and observational study of 2595 catheters Crit Care 9 2005 631 635
14. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
15. D.G. Maki, C.E. Weise, and H.W. Sarafin A semiquantitative culture method for identifying intravenous catheter-related infection N Engl J Med 296 1977 1305 1309
16. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
17. N.P. O'Grady, M. Alexander, L.A. Burns, E.P. Dellinger, J. Garland, S.O. Heard Healthcare Infection Control Practices Advisory Committee Guidelines for the prevention of intravascular catheter-related infections Am J Infect Control 39 2011 S1 34
18. R. Jee, L. Nel, G. Gnanakumaran, A. Williams, and E. Eren Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 103 2009 614 615
19. R. Stephens, M. Mythen, P. Kallis, D.W. Davies, W. Egner, and A. Rickards Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter Br J Anaesth 87 2001 306 308
20. E. Terazawa, H. Shimonaka, K. Nagase, T. Masue, and S. Dohi Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter Anesthesiology 89 1998 1296 1298